• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Myovant Sciences Ltd (NY: MYOV )

    N/A UNCHANGED
    Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Myovant Sciences Ltd

    < Previous 1 2 3 4 5 Next >
    The 2 Best Pharma Stocks to Buy on Dips
    Because the COVID-19 pandemic is under control in most major economies, the hype surrounding vaccine producers is gradually tapering off. 
    Via Talk Markets
    Exposures COVID-19
    3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
    The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. 
    Via Talk Markets
    Exposures COVID-19
    Looking Into Myovant Sciences's Return On Capital Employed
    During Q4, Myovant Sciences (NYSE:MYOV) brought in sales totaling $24.61 million. However, earnings decreased 1.75%, resulting in a loss of $76.95 million. Myovant Sciences... 
    Via Benzinga
    Myovant - Pfizer's Uterine Fibroids Treatment Wins FDA Approval
    The FDA has approved Myovant Sciences Ltd (NYSE: MYOV) and Pfizer Inc’s (NYSE: PFE) relugolix combined with estradiol and norethindrone acetate for... 
    Via Benzinga
    Exposures Product Safety
    Myovant Sciences' Relugolix Combo Tablet For Uterine Fibroids Scores EMA Backing For Approval
    European Medicines Agency's advisory committee issued a positive opinion recommending the approval of Myovant Sciences Ltd's (NYSE: MYOV) Ryeqo (... 
    Via Benzinga
    Earnings Scheduled For May 11, 2021
    Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
    Via Benzinga
    The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
    Via Benzinga
    Exposures COVID-19
    Myovant Stock Is Trading Lower After FDA Slapped Clinical Hold On Relugolix Combo Study
    Myovant Sciences Ltd (NYSE: MYOV) has received a partial clinical hold on its SERENE study (MVT-601-050) from the FDA. The Phase 3 study was evaluating relugolix... 
    Via Benzinga
    Exposures Product Safety
    Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript
    MYOV earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    9 Health Care Stocks Showing Unusual Options Activity In Today's Session
    This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
    Via Benzinga
    Return On Capital Employed Overview: Myovant Sciences
    Myovant Sciences (NYSE:MYOV) reported Q4 sales of $24.61 million. Earnings fell to a loss of $76.95 million, resulting in a 1.75% decrease from last quarter. In Q3, Myovant... 
    Via Benzinga
    Myovant Sciences: Q4 Earnings Insights
    Shares of Myovant Sciences (NYSE:MYOV) moved higher by 4.5% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 21.... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
    Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.